{"id":399195,"date":"2025-05-25T01:05:00","date_gmt":"2025-05-24T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/citocinas-th2-en-el-punto-de-mira-puntos-de-ataque-probados-y-nuevos\/"},"modified":"2025-05-24T23:00:42","modified_gmt":"2025-05-24T21:00:42","slug":"citocinas-th2-en-el-punto-de-mira-puntos-de-ataque-probados-y-nuevos","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/citocinas-th2-en-el-punto-de-mira-puntos-de-ataque-probados-y-nuevos\/","title":{"rendered":"Citocinas Th2 en el punto de mira: puntos de ataque probados y nuevos"},"content":{"rendered":"\n<p><strong>La gama de terapias con anticuerpos para la dermatitis at\u00f3pica (DA) ha vuelto a ampliarse en Europa. Adem\u00e1s del dupilumab y el tralokinumab, el lebrikizumab es otro biol\u00f3gico disponible en este pa\u00eds que interviene espec\u00edficamente en la cascada inflamatoria y tiene un perfil de seguridad impresionante. En la UE tambi\u00e9n se ha autorizado recientemente el nemolizumab para la EA.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fcitocinas-th2-en-el-punto-de-mira-puntos-de-ataque-probados-y-nuevos%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La gama de terapias con anticuerpos para la dermatitis at\u00f3pica (DA) ha vuelto a ampliarse en Europa. Adem\u00e1s del dupilumab y el tralokinumab, el lebrikizumab es otro biol\u00f3gico disponible en&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fcitocinas-th2-en-el-punto-de-mira-puntos-de-ataque-probados-y-nuevos%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":399198,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Biol\u00f3gicos para la dermatitis at\u00f3pica  ","footnotes":""},"category":[11298,11310,11483,11475,11408,11552],"tags":[65573,82425,82424,12425,82422,12531,13573,16249,82423,82421,65669,13309],"powerkit_post_featured":[],"class_list":["post-399195","post","type-post","status-publish","format-standard","has-post-thumbnail","category-alergologia-e-inmunologia-clinica","category-dermatologia-y-venereologia","category-el-congreso-informa","category-estudios","category-farmacologia-y-toxicologia","category-rx-es","tag-adtralza-es","tag-advocate-es","tag-arcadia-es","tag-biologicos-es","tag-citocinas-th2-es","tag-dermatitis-atopica","tag-dupilumab-es","tag-dupixent-es","tag-ebglyss-es","tag-lebrikizumab-es","tag-nemolizumab-es","tag-tralokinumab-es","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-15 22:28:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/399195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=399195"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/399195\/revisions"}],"predecessor-version":[{"id":399199,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/399195\/revisions\/399199"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/399198"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=399195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=399195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=399195"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=399195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}